BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12890905)

  • 1. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease.
    Matsui K; Yoshioka T; Murakami Y; Takahashi M; Shimada K; Ikeda U
    Circ J; 2003 Aug; 67(8):660-2. PubMed ID: 12890905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
    Idei N; Nishioka K; Soga J; Hidaka T; Hata T; Fujii Y; Fujimura N; Maruhashi T; Mikami S; Teragawa H; Kihara Y; Noma K; Chayama K; Higashi Y
    Hypertension; 2011 Jan; 57(1):70-8. PubMed ID: 21115876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
    Varney ML; Olsen KJ; Mosley RL; Singh RK
    J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum lipids and lipoproteins in peripheral vascular disease].
    Umemoto T
    Nihon Geka Gakkai Zasshi; 1985 Jan; 86(1):84-97. PubMed ID: 3974570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of non-osteogenic factors on the expression of M-CSF and VEGF during fracture healing.
    Köttstorfer J; Kaiser G; Thomas A; Gregori M; Kecht M; Domaszewski F; Sarahrudi K
    Injury; 2013 Jul; 44(7):930-4. PubMed ID: 23570706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating angiogenic factors in patients with thromboangiitis obliterans.
    Hewing B; Stangl V; Stangl K; Enke-Melzer K; Baumann G; Ludwig A
    PLoS One; 2012; 7(4):e34717. PubMed ID: 22506045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis.
    Okazaki T; Ebihara S; Takahashi H; Asada M; Kanda A; Sasaki H
    J Immunol; 2005 Jun; 174(12):7531-8. PubMed ID: 15944252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth.
    Bersinger NA; Ødegård RA
    Am J Reprod Immunol; 2005 Aug; 54(2):77-83. PubMed ID: 16105099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates.
    Oren H; Duman N; Abacioglu H; Ozkan H; Irken G
    Pediatrics; 2001 Aug; 108(2):329-32. PubMed ID: 11483796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
    Zajkowska M; Głażewska EK; Będkowska GE; Chorąży P; Szmitkowski M; Ławicki S
    Mediators Inflamm; 2016; 2016():5962946. PubMed ID: 27445439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia.
    Luo JY; Wu GF; Xiong Y; Chen GW; Xie Q; Yang DY; He XH; Zhang Y; Liu DH; Wang KJ; Ma H; Zheng ZS; DU ZM
    Chin Med J (Engl); 2009 May; 122(10):1188-94. PubMed ID: 19493469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Difference between Growth Factor Expression after Single and Multiple Fractures: Preliminary Results in Human Fracture Healing.
    Binder H; Eipeldauer S; Gregori M; Höchtl-Lee L; Thomas A; Tiefenboeck TM; Hajdu S; Sarahrudi K
    Dis Markers; 2015; 2015():203136. PubMed ID: 26246654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influenced on prognosis of reconstructive surgery for peripheral arterial occlusion: comparative study between arteriosclerosis obliterans and thromboangiitis obliterans.
    Nakata Y; Kawai S; Matsubara J; Ban I; Shionoya S
    J Cardiovasc Surg (Torino); 1977; 18(6):547-53. PubMed ID: 599159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of red cell deformability and lipid composition of red cell membrane in chronic arterial occlusive diseases].
    Sawamura T
    Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):378-91. PubMed ID: 6749110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans.
    Fazeli B; Rafatpanah H; Ravari H; Hosseini RF; Rezaee SA
    Vascular; 2014 Jun; 22(3):174-80. PubMed ID: 23567329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclic tensile forces on the expression of vascular endothelial growth factor (VEGF) and macrophage-colony-stimulating factor (M-CSF) in murine osteoblastic MC3T3-E1 cells.
    Motokawa M; Kaku M; Tohma Y; Kawata T; Fujita T; Kohno S; Tsutsui K; Ohtani J; Tenjo K; Shigekawa M; Kamada H; Tanne K
    J Dent Res; 2005 May; 84(5):422-7. PubMed ID: 15840777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of serum lipoprotein(a) in patients with ischemic heart disease with normal coronary angiogram and thromboangiitis obliterans.
    Takami S; Kubo M; Yamashita S; Kameda-Takemura K; Kawasaki T; Kanbayashi J; Nakamura Y; Yokoi Y; Ohnishi K; Matsuzawa Y
    Atherosclerosis; 1995 Jan; 112(2):253-60. PubMed ID: 7772084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.
    Okazaki T; Ebihara S; Asada M; Yamanda S; Saijo Y; Shiraishi Y; Ebihara T; Niu K; Mei H; Arai H; Yambe T
    Am J Pathol; 2007 Oct; 171(4):1093-103. PubMed ID: 17717142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S; Będkowska GE; Szmitkowski M
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.